Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53


A randomized controlled trial of an internet-based intervention for alcohol abusers.

Cunningham JA, Wild TC, Cordingley J, van Mierlo T, Humphreys K.

Addiction. 2009 Dec;104(12):2023-32. doi: 10.1111/j.1360-0443.2009.02726.x.


Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions.

McBride CM, Alford SH, Reid RJ, Larson EB, Baxevanis AD, Brody LC.

Genet Med. 2009 Aug;11(8):582-7. doi: 10.1097/GIM.0b013e3181b22c3a.


Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.

Sanderson SC, O'Neill SC, White DB, Bepler G, Bastian L, Lipkus IM, McBride CM.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):1953-61. doi: 10.1158/1055-9965.EPI-08-0620. Epub 2009 Jun 30.


Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.

Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J.

Lancet. 2009 Jun 27;373(9682):2223-33. doi: 10.1016/S0140-6736(09)60746-7.


Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests.

Cameron LD, Sherman KA, Marteau TM, Brown PM.

Health Psychol. 2009 May;28(3):307-16. doi: 10.1037/a0013947.


Genetic risk prediction--are we there yet?

Kraft P, Hunter DJ.

N Engl J Med. 2009 Apr 23;360(17):1701-3. doi: 10.1056/NEJMp0810107. Epub 2009 Apr 15. No abstract available.


Does genomic risk information motivate people to change their behavior?

Henrikson NB, Bowen D, Burke W.

Genome Med. 2009 Apr 2;1(4):37. doi: 10.1186/gm37.


Genome-based prediction of common diseases: methodological considerations for future research.

Janssens AC, van Duijn CM.

Genome Med. 2009 Feb 18;1(2):20. doi: 10.1186/gm20.


Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism.

Lachenmeier DW, Kanteres F, Rehm J.

Addiction. 2009 Apr;104(4):533-50. doi: 10.1111/j.1360-0443.2009.02516.x. Review.


The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption.

Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A.

PLoS Med. 2009 Mar 24;6(3):e50. doi: 10.1371/journal.pmed.1000050. Review. No abstract available.


Associations of ALDH2 and ADH1B genotypes with alcohol-related phenotypes in Asian young adults.

Hendershot CS, Collins SE, George WH, Wall TL, McCarthy DM, Liang T, Larimer ME.

Alcohol Clin Exp Res. 2009 May;33(5):839-47. doi: 10.1111/j.1530-0277.2009.00903.x. Epub 2009 Mar 6.


Internet-based personalized feedback to reduce 21st-birthday drinking: a randomized controlled trial of an event-specific prevention intervention.

Neighbors C, Lee CM, Lewis MA, Fossos N, Walter T.

J Consult Clin Psychol. 2009 Feb;77(1):51-63. doi: 10.1037/a0014386.


Clinical risk factors, DNA variants, and the development of type 2 diabetes.

Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D, Nilsson P, Groop L.

N Engl J Med. 2008 Nov 20;359(21):2220-32. doi: 10.1056/NEJMoa0801869.


Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.

van Hoek M, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, Oostra BA, Hofman A, Sijbrands EJ, Janssens AC.

Diabetes. 2008 Nov;57(11):3122-8. doi: 10.2337/db08-0425. Epub 2008 Aug 11.


Prediction of individual genetic risk of complex disease.

Wray NR, Goddard ME, Visscher PM.

Curr Opin Genet Dev. 2008 Jun;18(3):257-63. doi: 10.1016/j.gde.2008.07.006. Epub 2008 Aug 28. Review.


Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk.

Lango H; UK Type 2 Diabetes Genetics Consortium, Palmer CN, Morris AD, Zeggini E, Hattersley AT, McCarthy MI, Frayling TM, Weedon MN.

Diabetes. 2008 Nov;57(11):3129-35. doi: 10.2337/db08-0504. Epub 2008 Jun 30.


Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial.

Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J.

J Health Psychol. 2008 May;13(4):481-94. doi: 10.1177/1359105308088519.


Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.

Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC.

Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):94-7. doi: 10.1097/WAD.0b013e31815a9dcc.


Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis.

Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP.

Am J Epidemiol. 2008 Apr 1;167(7):759-74. doi: 10.1093/aje/kwm383. Epub 2008 Feb 12.


Supplemental Content

Support Center